HIV Citation List: April 15, 2011 - April 28, 2011

Pubmed citations

1. Inhibitors of the Interactions between HIV-1 in and the Cofactor Ledgf/P75. De Luca, L., S. Ferro, F. Morreale, S. De Grazia, and A. Chimirri. ChemMedChem, 2011. [Epub ahead of print]; PMID[21506277].

[Pubmed]. HIV_0415-042811.

2. Asymmetric Total Synthesis of (+)- and (-)-Clusianone and (+)- and (-)-Clusianone Methyl Enol Ether Via Acc Alkylation and Evaluation of Their Anti-HIV Activity. Garnsey, M.R., J.A. Matous, J.J. Kwiek, and D.M. Coltart. Bioorganic & Medicinal Chemistry Letters, 2011. 21(8): p. 2406-2409; PMID[21414776].

[Pubmed]. HIV_0415-042811.

3. Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors. Johnson, T.W., S.P. Tanis, S.L. Butler, D. Dalvie, D.M. Delisle, K.R. Dress, E.J. Flahive, Q. Hu, J.E. Kuehler, A. Kuki, W. Liu, G.A. McClellan, Q. Peng, M.B. Plewe, P.F. Richardson, G.L. Smith, J. Solowiej, K.T. Tran, H. Wang, X. Yu, J. Zhang, and H. Zhu. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21446745].

[Pubmed]. HIV_0415-042811.

4. Inhibition of Tat-Mediated HIV-1 Replication and Neurotoxicity by Novel Gsk3-Beta Inhibitors. Kehn-Hall, K., I. Guendel, L. Carpio, L. Skaltsounis, L. Meijer, L. Al-Harthi, J.P. Steiner, A. Nath, O. Kutsch, and F. Kashanchi. Virology, 2011. [Epub ahead of print]; PMID[21514616].

[Pubmed]. HIV_0415-042811.

5. 5'-Phosphonate Derivatives of 2',3'-Dideoxy-3'-Thiacytidine as New Anti-HIV Prodrugs. Khandazhinskaya, A.L., M.V. Jasko, I.L. Karpenko, P.N. Solyev, N.A. Golubeva, and M.K. Kukhanova. Chemical Biology and Drug Design, 2011. [Epub ahead of print]; PMID[21518262].

[Pubmed]. HIV_0415-042811.

6. Increasing Hydrophobicity of Residues in an Anti-HIV-1 Env Peptide Synergistically Improves Potency. Leung, M.Y. and F.S. Cohen. Biophysical Journal, 2011. 100(8): p. 1960-1968; PMID[21504732].

[Pubmed]. HIV_0415-042811.

7. A Single Polymorphism in HIV-1 Subtype C Sp1 Is Sufficient to Confer Natural Resistance to the Maturation Inhibitor, Bevirimat. Lu, W., K. Salzwedel, D. Wang, S. Chakravarty, E.O. Freed, C.T. Wild, and F. Li. Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21502630].

[Pubmed]. HIV_0415-042811.

8. Pentacycloundecane-Based Inhibitors of Wild-Type C-South African HIV-Protease. Makatini, M.M., K. Petzold, S.N. Sriharsha, M.E. Soliman, B. Honarparvar, P.I. Arvidsson, Y. Sayed, P. Govender, G.E. Maguire, H.G. Kruger, and T. Govender. Bioorganic & Medicinal Chemistry Letters, 2011. 21(8): p. 2274-2277; PMID[21429747].

[Pubmed]. HIV_0415-042811.

9. High-Throughput Screening Uncovers a Compound That Activates Latent HIV-1 and Acts Cooperatively with a Hdac Inhibitor. Micheva-Viteva, S., Y. Kobayashi, L.C. Edelstein, A.L. Pacchia, H.L. Lee, J.D. Graci, J. Breslin, B.D. Phelan, L.K. Miller, J.M. Colacino, Z. Gu, Y. Ron, S.W. Peltz, and J.P. Dougherty. Journal of Biological Chemistry, 2011. [Epub ahead of print]; PMID[21498519].

[Pubmed]. HIV_0415-042811.

10. Inhibition of HIV-1 Infection by Aqueous Extracts of Prunella Vulgaris L. Oh, C., J.P. Price, M.A. Brindley, M.P. Widrlechner, L. Qu, J.A. McCoy, P. Murphy, C. Hauck, and W. Maury. Virology Journal, 2011. 8(1): p. 188; PMID[21513560].

[Pubmed]. HIV_0415-042811.

11. Overcoming Hurdles in Developing Successful Drugs Targeting Chemokine Receptors. Schall, T.J. and A.E. Proudfoot. Nature Reviews Immunology, 2011. 11(5): p. 355-363; PMID[21494268].

[Pubmed]. HIV_0415-042811.

12. Design and Synthesis of Pyridin-2-Yloxymethylpiperidin-1-Ylbutyl Amide Ccr5 Antagonists That Are Potent Inhibitors of M-Tropic (R5) HIV-1 Replication. Skerlj, R., G. Bridger, Y. Zhou, E. Bourque, J. Langille, M.D. Fluri, D. Bogucki, W. Yang, T. Li, L. Wang, S. Nan, I. Baird, M. Metz, M. Darkes, J. Labrecque, G. Lau, S. Fricker, D. Huskens, and D. Schols. Bioorganic & Medicinal Chemistry Letters, 2011. 21(8): p. 2450-2455; PMID[21398122].

[Pubmed]. HIV_0415-042811.

13. 6-Benzoyl-3-Hydroxypyrimidine-2,4-Diones as Dual Inhibitors of HIV Reverse Transcriptase and Integrase. Tang, J., K. Maddali, C.D. Dreis, Y.Y. Sham, R. Vince, Y. Pommier, and Z. Wang. Bioorganic & Medicinal Chemistry Letters, 2011. 21(8): p. 2400-2402; PMID[21392991].

[Pubmed]. HIV_0415-042811.

14. The Role of Conserved Glu Residue on Cyclotide Stability and Activity: A Structural and Functional Study of Kalata B12, a Naturally Occurring Glu to Asp Mutant. Wang, C.K., R.J. Clark, P.J. Harvey, K. Johan Rosengren, M. Cemazar, and D.J. Craik. Biochemistry, 2011. [Epub ahead of print]; PMID[21466163].

[Pubmed]. HIV_0415-042811.

ISI Web of Knowledge citations

15. Sulfated Polysaccharides in Marine Sponges: Extraction Methods and Anti-HIV Activity. Esteves, A.I.S., M. Nicolai, M. Humanes, and J. Goncalves. Marine Drugs, 2011. 9(1): p. 139-153; ISI[000288892000010].

[WOS]. HIV_0415-042811.

16. Poly(HEMA-Zidovudine) Conjugate: A Macromolecular Pro-Drug for Improvement in the Biopharmaceutical Properties of the Drug. Neeraj, A., M.J.N. Chandrasekar, U.V.S. Sara, and A. Rohini. Drug Delivery, 2011. 18(4): p. 272-280; ISI[000288900100006].

[WOS]. HIV_0415-042811.

17. A Novel Metalloprotease from the Wild Basidiomycete Mushroom Lepista nuda. Wu, Y.Y., H.X. Wang, and T.B. Ng. Journal of Microbiology and Biotechnology, 2011. 21(3): p. 256-262; ISI[000289008400005].

[WOS]. HIV_0415-042811.

18. Synthesis and Biological Activity of Lamellarin Alkaloids: an Overview. Fukuda, T., F. Ishibashi, and M. Iwao. Heterocycles, 2011. 83(3): p. 491-529; ISI[000289017700002].

[WOS]. HIV_0415-042811.

19. Role of Hydroxymethyl Group as a New Hydrophilic 4 '-Pocket in 5 '-Norcarbocyclic Nucleoside Analogues. Liu, L.J. and J.H. Hong. Bulletin of the Korean Chemical Society, 2011. 32(2): p. 411-416; ISI[000289038200007].

[WOS]. HIV_0415-042811.

20. Carba-LNA Modified siRNAs Targeting HIV-1 TAR Region Downregulate HIV-1 Replication Successfully with Enhanced Potency. Dutta, S., N. Bhaduri, N. Rastogi, S.G. Chandel, J.K. Vandavasi, R.S. Upadhayaya, and J. Chattopadhyaya. Medchemcomm, 2011. 2(3): p. 206-216; ISI[000289040100010].

[WOS]. HIV_0415-042811.

21. Viral Surface Glycoproteins, gp120 and gp41, as Potential Drug Targets Against HIV-1: Brief Overview One Quarter of a Century Past the Approval of Zidovudine, the first anti-retroviral drug. Teixeira, C., J.R.B. Gomes, P. Gomes, and F. Maurel. European Journal of Medicinal Chemistry, 2011. 46(4): p. 979-992; ISI[000289048400001].

[WOS]. HIV_0415-042811.

22. Synthesis, Biopharmaceutical Characterization, Antimicrobial and Antioxidant Activities of 1-(4 '-O-beta-D-Glucopyranosyloxy-2 '-hydroxyphenyl)-3-aryl-propane-1,3-diones. Sheikh, J., A. Parvez, H. Juneja, V. Ingle, Z. Chohan, M. Youssoufi, and T. Ben Hadda. European Journal of Medicinal Chemistry, 2011. 46(4): p. 1390-1399; ISI[000289048400043].

[WOS]. HIV_0415-042811.

23. Novel Histone Deacetylase Inhibitor NCH-51 Activates Latent HIV-1 Gene Expression. Victoriano, A.F.B., K. Imai, H. Togami, T. Ueno, K. Asamitsu, T. Suzuki, N. Miyata, K. Ochiai, and T. Okamoto. FEBS Letters, 2011. 585(7): p. 1103-1111; ISI[000289057800027].

[WOS]. HIV_0415-042811.

24. PentacycloundecaneBbased Inhibitors of Wild-Type C-South African HIV-Protease. Makatini, M.M., K. Petzold, S.N. Sriharsha, M.E.S. Soliman, B. Honarparvar, P.I. Arvidsson, Y. Sayed, P. Govender, G.E.M. Maguire, H.G. Kruger, and T. Govender. Bioorganic & Medicinal Chemistry Letters, 2011. 21(8): p. 2274-2277; ISI[000289074700020].

[WOS]. HIV_0415-042811.

25. 6-Benzoyl-3-hydroxypyrimidine-2,4-diones as Dual Inhibitors of HIV Reverse Transcriptase and Integrase. Tang, J., K. Maddali, C.D. Dreis, Y.Y. Sham, R. Vince, Y. Pommier, and Z.Q. Wang. Bioorganic & Medicinal Chemistry Letters, 2011. 21(8): p. 2400-2402; ISI[000289074700047].

[WOS]. HIV_0415-042811.

26. Design and Synthesis of Pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 Antagonists that are Potent Inhibitors of M-Tropic (R5) HIV-1 Replication. Skerlj, R., G. Bridger, Y.X. Zhou, E. Bourque, J. Langille, M. Di Fluri, D. Bogucki, W. Yang, T.S. Li, L.T. Wang, S. Nan, I. Baird, M. Metz, M. Darkes, J. Labrecque, G. Lau, S. Fricker, D. Huskens, and D. Schols. Bioorganic & Medicinal Chemistry Letters, 2011. 21(8): p. 2450-2455; ISI[000289074700058].

[WOS]. HIV_0415-042811.

27. Enhanced Anti-HIV-1 Activity of G-Quadruplexes Comprising Locked Nucleic Acids and Intercalating Nucleic Acids. Pedersen, E.B., J.T. Nielsen, C. Nielsen, and V.V. Filichev. Nucleic Acids Research, 2011. 39(6): p. 2470-2481; ISI[000289166400048].

[WOS]. HIV_0415-042811.

28. RNA-Binding and Viral Reverse Transcriptase Inhibitory Activity of a Novel Cationic Diamino Acid-Based Peptide. Roviello, G.N., S. Di Gaetano, D. Capasso, S. Franco, C. Crescenzo, E.M. Bucci, and C. Pedonet. Journal of Medicinal Chemistry, 2011. 54(7): p. 2095-2101; ISI[000289215700011].

[WOS]. HIV_0415-042811.

29. 3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase. Tang, J., K. Maddali, M. Metifiot, Y.Y. Sham, R. Vince, Y. Pommier, and Z.Q. Wang. Journal of Medicinal Chemistry, 2011. 54(7): p. 2282-2292; ISI[000289215700025].

[WOS]. HIV_0415-042811.

30. Synthesis and Preliminary Anti-HIV Activities of Andrographolide Derivatives. Wang, B., L.A. Ge, W.L. Huang, H.B. Zhang, H. Qian, J. Li, and Y.T. Zheng. Medicinal Chemistry, 2010. 6(4): p. 252-258; ISI[000289267800010].

[WOS]. HIV_0415-042811.

31. Value of Antiretroviral CNS Penetration-Effectiveness (CPE) 2010 Rankings in Predicting CSF HIV Replication According With Rate of Viral Supression in Plasma. Picchi, G., M.L. Giancola, P. Lorenzini, F. Baldini, L. Monno, A. Ammassari, A.D. Monforte, P. Cinque, V. Tozzi, and A. Antinori. Infection, 2011. 39(S1): p. S20-S20; ISI[000288832500024].

[WOS]. HIV_0415-042811.

32. Dual/Mixed (But not X4) Tropic-HIV-1 Isolates Can Replicate in Human Primary Macrophages and are Inhibited by CCR5-Inhibitors. Surdo, M., E. Balestra, P. Saccomandi, F. Di Santo, V. Svicher, C. Alteri, V. Canto, M. Pollicita, F. Scopelliti, M. Andreoni, S. Aquaro, F. Ceccherini-Silberstein, and C.F. Perno. Infection, 2011. 39(S1): p. S23-S23; ISI[000288832500029].

[WOS]. HIV_0415-042811.

33. Development of Recombinant Virus Assays for Phenotypic Evaluation of the Susceptibility to Integrase Inhibitors and HIV Coresceptor Tropism. Saladini, F., A. Rosi, I. Vincenti, G. Meini, and M. Zazzi. Infection, 2011. 39(S1): p. S39-S40; ISI[000288832500066].

[WOS]. HIV_0415-042811.

34. Protease Inhibitors and HIV-Related Demyelinating Polyneuropathies: a New Possible Treatment? Ceccarelli, G., A. Clemenzi, G. Antonini, C. Rizza, G. D'Ettorre, and V. Vullo. Infection, 2011. 39(S1): p. S83-S83; ISI[000288832500172].

[WOS]. HIV_0415-042811.

35. A Glycomimetic Compound Inhibits DC-SIGN Mediated HIV Infection in Cellular and Cervical Explant Models. Berzi, A., S. Sattin, J. Reina, M. Sanchez-Navarro, J. Rojo, D. Trabattoni, P. Antonazzo, I. Cetin, A. Bernardi, and M. Clerici. Infection, 2011. 39(S1): p. S11-S12; ISI[000288832500003].

[WOS]. HIV_0415-042811.

Patent citations

36. Preparation of 2(1H)-pyridinone derivatives as HIV-1 reverse transcriptase inhibitors. Li, A., X. Wang, L. Ma, Y. Shao, and J. Liu. Patent. 2011. 2010-10515280 102001994.

[Patent]. HIV_0415-042811.

37. Preparation of heterocyclic compounds and N-aryl urea derivatives with DDX3 inhibitory activity and their use in the treatment of neoplasm and viral infection. Radi, M., M. Botta, F. Falchi, G. Maga, F. Baldanti, and S. Paolucci. Patent. 2011. 2010-IB54475 2011039735.

[Patent]. HIV_0415-042811.

38. Peptides derived from α1-antitrypsin for the treatment of viral infection.. Shapiro, L. Patent. 2011. 2010-US50581 2011041325.

[Patent]. HIV_0415-042811.